New York City's health department website crashed for the second time because an "overwhelming" number of people tried making appointments for a monkeypox vaccine, according to The Hill.

The U.S. is set to soon have a fourth COVID-19 vaccine option after the FDA authorized Novavax's vaccine for emergency use in adults July 13. 

As some hospitals and health systems flounder to care for patients after some states have banned or severely restricted abortions, the HHS instructed national retail pharmacies on July 13 to continue handing out reproductive health medication and other drugs that have been affected by abortion restrictions. 

Antidepressant prescriptions climbed 8.7 percent since 2019, but some age groups fronted more of the burden, according to The New York Times.

Teva Pharmaceuticals will settle a San Francisco lawsuit, which accused the company of fueling the opioid epidemic in the city through the sale of highly addictive painkillers, for $24.8 million to be paid over 13 years, according to a July 12 press release. 

Kenilworth, N.J.-based Merck will pay Orion $290 million in a global development and commercialization agreement for the Finland-based pharmaceutical company's oral inhibitor that aims to treat advanced prostate cancer. 

With staffing shortages hindering healthcare systems, some are turning to robots to help understaffed workers — an effort that's paying off for Pittsburgh-based Allegheny Health Network, a 14-hospital system. 

Four pharmacy executive moves Becker's has covered since July 1:

Burlingame, Calif.-based pharmaceutical company Innoviva plans to write a check for $149 million to acquire La Jolla Pharmaceutical after both boards of directors approved the transaction. 

A new COVID-19 omicron subvariant, BA.2.75, has appeared amid a rising case count spurred by other variants, and early data suggests it's more transmissible than other strains. Here's what that could mean for vaccines. 

The following 10 hospitals, health systems and hospital operators have posted job listings seeking pharmacy leaders in the last week.

As vaccine-makers race to show promising results for their updated, omicron-targeted vaccines set to debut this fall, Moderna forged ahead to prove its candidate is nearly twice as effective as its original vaccine. 

The U.S. bought 3.2 million doses of Novavax's two-shot COVID-19 vaccine July 11 despite the vaccine-maker still waiting FDA authorization over the next few weeks. 

HRA Pharma is eyeing FDA approval to allow its daily birth control pill to forgo prescriptions. If it pans out, the over-the-counter drug would be the first of its kind.

San Diego-based Emerald Health Pharmaceuticals announced CEO Jim DeMesa, MD, and CFO Lisa Sanford have resigned in a July 11 press release shared with Becker's.

California is the first state to challenge the pharmaceutical industry after Gov. Gavin Newsom allotted $100 million to launch CalRx, the state's insulin brand.

The Supreme Court's decision to overturn Roe v. Wade isn't just suppressing access to Plan B and abortion pills: The Washington Post and Time have reported consumers raising alarms about a chemotherapy and autoimmune drug. 

Half a year has passed since the FDA authorized Pfizer's at-home COVID-19 treatment Paxlovid for emergency use, and the two-pill regimen became the nation's No. 1 prescribed choice by the end of May. 

With the hopes of broadening access to COVID-19 care, the FDA on July 6 allowed pharmacists to prescribe Pfizer's antiviral treatment Paxlovid — but the AMA president disagrees with the decision. 

Pharmaceutical company Bausch Health said it will impose restrictions on 340B drug pricing discount programs for  safety-net providers, according to 340B Health's website.